Navigation Links
Decriminalizing pot may land more kids in the ER
Date:2/5/2014

WASHINGTON States that decriminalized marijuana saw dramatic increases in children requiring medical intervention, although the overall number of unintentional marijuana exposures among children remained low. The Annals of Emergency Medicine study of call volume to U.S. poison centers from January 2005 through December 2011 will be published online today ("Association of Unintentional Pediatric Exposures with Decriminalization of Marijuana in the U.S.").

"We believe that high-dose edible products such as candies, cookies and chocolates may have played a significant role in the increased rate of reported exposure chiefly because kids can't distinguish between products that contain marijuana and those that don't," said lead study author George Sam Wang, MD, of the Rocky Mountain Poison and Drug Center in Denver, Colo. "These edible products may be attractive to children and tend to contain higher concentrations of the active ingredient, tetrahydrocannabinol."

The call rate to poison centers in states that decriminalized marijuana increased by more than 30 percent per year between 2005 and 2011, while the call rate in non-legal states did not change. More pediatric exposures in decriminalized states than in non-legal states required medical evaluation, had moderate to major clinical effects and required critical care admissions. Neurologic effects were the most common. The most common therapy was administration of intravenous fluids. Aggressive interventions were rare and there were no deaths.

As of December 2013, 18 states and the District of Columbia had passed legislation allowing medical marijuana, which includes many edible products. Sales are projected to more than double between 2011 and 2015.

"Pediatricians, toxicologists and emergency physicians need to be willing to advocate for the safety of children to lawmakers as this burgeoning industry expands across the U.S.," said Dr. Wang. "As more states decriminalize marijuana, lawmakers should consider requirements such as child-resistant packaging, warning labels and public education to reduce the likelihood of ingestion by young children."


'/>"/>

Contact: Julie Lloyd
jlloyd@acep.org
202-370-9292
American College of Emergency Physicians
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... priced an offering of €500.0 million principal amount of its ... amount of its 2.425% senior unsecured notes due 2026. ... occur on December 13, 2016, subject to the satisfaction of customary ... basis. The Company intends to ...
(Date:12/6/2016)... Dec. 6, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... today a five (5) year funding commitment by ... expand the rehabilitation and reentry support to more ... Established in 2004, the Prison Entrepreneurship Program (PEP) ...
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , ... December 08, 2016 , ... ... in the World Technology Awards. uBiome is one of just six company finalists ... categories. , In addition to uBiome, companies nominated as finalists in this year’s ...
(Date:12/8/2016)... PRINCETON, N.J. , Dec. 8, 2016 /PRNewswire/ ... a late-stage biopharmaceutical company focused on developing and ... is an unmet medical need, announced today the ... trial with SGX942 (dusquetide), a first-in-class Innate Defense ... (OM) in head and neck cancer patients undergoing ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, ... that discovers, develops and plans to commercialize innovative ... shares of common stock were approved for trading ... begin trading on the OTCQX, effective today, under ... for the OTCQX market, companies must meet high ...
(Date:12/8/2016)... South Korea , Dec. 8, 2016 ... a $21 billion KRW (US $18.9M) Series A financing. ... Kolon Investment, G.N. Tech Venture and SNU Bio Angel. ... Eutilex to 30.5 billion KRW (US $27.7M) since its ... help Eutilex to bolster the development and commercialization of ...
Breaking Biology Technology: